Major Growth Influencing Factors:
Factors such as growing R&D expenditure from pharmaceutical and biopharmaceutical companies, the increasing R&D pipeline creating a need for increased analytical testing outsourcing, initiatives for research on rare diseases and orphan drugs, and the high cost of in-house drug development are positively driving the growth of the drug discovery services market.
Additionally, technological advancements, the introduction of new drug discovery techniques, the expiry of patents, and rising demand for specialized testing services among end users are expected to offer growth opportunities to players in this market.
Global Leading Companies:
The global drug discovery services market is competitive, with Laboratory Corporation of America Holdings (US), Charles River Laboratories International Inc. (US), Thermo Fisher Scientific Inc. (US), and WuXi AppTec (China) together major share of the global market.
Laboratory Corporation of America Holdings (US) is one of the leading players in the global drug discovery services market. The company’s strong focus on a broad range of customers, technology-enabled solutions, investments in joint ventures & partnerships, and comprehensive quality systems and processes contribute to the growth of the company’s market share.
The company focuses on organic and inorganic growth strategies such as acquisitions and expansions to enhance its share in the global drug discovery services market. For example, it acquired Toxicon to expand its footprint in the bioanalytical testing market. Additionally, in December 2022, LabCorp opened a new anatomic pathology and histology (APH) laboratory in Los Angeles.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129
Charles River Laboratories (US) is headquartered in the United States and has a significant global presence. They operate in numerous countries, including the United States, Canada, the United Kingdom, Germany, France, Spain, Italy, China, Japan, Singapore, and many others. Their extensive network of facilities allows them to serve clients globally and provide drug discovery services across different regions.
With their global reach, Charles River Laboratories can support drug discovery projects at various stages, including target identification and validation, hit-to-lead optimization, medicinal chemistry, in vitro and in vivo pharmacology, safety assessment, and regulatory support.
Thermo Fisher Scientific (US) offers a complete and integrated portfolio of discovery services. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. The company gained over USD 14 billion in revenue in 2021 from its Life Sciences Solutions segment, which provides drug discovery services. In October 2022, Thermo Fisher expanded its facilities in Kentucky (US) and Virginia (US) to provide drug discovery and development services. In 2021, it acquired PPD, adding to its discovery services portfolio.
WuXi AppTec (China) is a leading global contract research organization (CRO) headquartered in China. The company provides a wide range of drug discovery and development services to pharmaceutical, biotechnology, and medical device companies worldwide.
WuXi AppTec has a strong global presence and operates in various regions across the world. They have established facilities and offices in multiple countries to serve their clients effectively.
Different Growth Strategies Adopted by Key Players:
Key players in the Drug Discovery Services Market employ various growth strategies to expand their market presence and enhance their competitive position. Some of the common growth strategies adopted by these companies include:
Partnerships and Collaborations: Companies often enter into strategic partnerships and collaborations with other pharmaceutical companies, biotechnology firms, academic institutions, and research organizations. These collaborations allow them to combine expertise, resources, and technologies to accelerate drug discovery and development processes.
Acquisitions and Mergers: Acquiring or merging with other companies is a common strategy to expand capabilities, access new technologies, and enter new markets. By acquiring specialized CROs or research facilities, companies can broaden their service offerings and gain a competitive advantage.
Expansion of Facilities: Key players often invest in expanding their existing facilities or establishing new ones in strategic locations. This allows them to cater to a larger client base, increase operational efficiency, and meet growing demand for drug discovery services.
Focus on Research and Development: Investing in research and development (R&D) activities is crucial for companies to stay at the forefront of innovation. By developing new technologies, platforms, and methodologies, companies can enhance their service offerings, attract new clients, and differentiate themselves in the market.
Geographic Expansion: Companies may focus on expanding their geographical reach by entering new regions or strengthening their presence in existing markets. This expansion allows them to tap into emerging markets, access local talent and resources, and serve a more diverse client base.
Portfolio Diversification: Key players often diversify their service portfolios to offer a comprehensive range of drug discovery services. This includes expanding into new areas such as genomics, proteomics, bioinformatics, and specialized therapeutic areas, catering to the evolving needs of the pharmaceutical and biotechnology industry.
Investment in Technological Advancements: Keeping up with technological advancements is essential in the drug discovery services market. Companies invest in cutting-edge technologies, automation, data analytics, and artificial intelligence to enhance efficiency, accelerate drug discovery processes, and improve decision-making.
Find More Detailed Information on "Emerging Trends & Future Forecasts in Drug Discovery Services Market", Here..!
No comments:
Post a Comment